Clinical Trial Search

Primary: Absolute Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 24 — -0.38; -0.74 percentage of hemoglobin — p=0.0002

Primary: Absolute Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 24 — -0.79; -0.96 percentage of hemoglobin

Primary: Emergence Agitation and Pain — 14; 10; 4; 3 units on a scale — p=.001

Primary: Creatinine Clearance at 1 Month After Transplantation — 65.82 mL/min

Primary: Incidence of Post-operative UTI Following the Placement of Sub-urethral Sling for the Treatment of Stress Urinary Incontinence — 13; 24 participants

Primary: Donor (Allogeneic) Hematopoietic Engraftment — 1 participants

Primary: Absolute Change From Baseline in Glycosylated Hemoglobin (HbA1c) at Week 24 — 0.11; -0.77 percentage of hemoglobin — p=<0.0001

Primary: Activity Endurance Time — 7.24; 13.38 minutes — p=<0.05

Primary: Change From Baseline in Area Under the Plasma Glucose Concentration Curve From Time 0.5 Hours to 4.5 Hours (GLU-AUC0:30-4:30h) at Day 28 — -227.25; -72.83 h*mg/dL…

Primary: Overall Survival (OS) — 13.4; 14.5 months

Primary: Change From Baseline in Mean "Off" Time (Hours Per Day) at Week 12 — -1.2; -1.0; -0.9; -0.5 Hours/Day — p=0.0564

Primary: Number of Patients With Surgical Site Infections — 42; 14; 25 participants

Primary: Systolic Blood Pressure Measurements — 131.8; 134.3; 122.1; 127.4 mmHg — p=<0.05

Primary: Part 2: Percentage of Treatment-naïve Participants in the Immediate Treatment Arm Achieving Sustained Viral Response at 12 Weeks After The End of All Treatment (SVR12)…

Primary: Reaction Time and Variability for Movement Task — 1013.858333; 994.94875; 979.2450877; 910.9120833 milliseconds